Found 75 matching trials
Venetoclax Plus CACAG Regimen for Newly Diagnosed Acute Myeloid Leukemia PHASE2 The purpose of this study is to compare the efficacy and safety of venetocl...
Show More Location
Chinese PLA General Hospital
Learn More & Join Trial
Ruxolitinib-Decitabine Intensified Conditioning Regimen for AML: A Randomized Trial PHASE4 This study aims to determine whether the recurrence rate of high-risk acute...
Show More Location
Chinese PLA General Hospital
Learn More & Join Trial
"InDACtion" vs "3+7" Induction in AML PHASE3 Older patients with acute myeloid leukemia (AML) have a small (\< 10%) chan...
Show More Learn More & Join Trial
Safety, Tolerability, Pharmacokinetics, and Efficacy of AZD2811 Nanoparticles as Monotherapy or in Combination in Acute Myeloid Leukemia Participants. PHASE1 This is a Phase I/II clinical study to determine the maximum tolerated dose...
Show More Learn More & Join Trial
Decitabine With or Without Interferon Alfa-2b in Treating Patients With Unresectable or Metastatic Solid Tumors PHASE1 This phase I trial is studying the side effects of decitabine when given to...
Show More Location
Nevada Cancer Institute-Summerlin Campus
Learn More & Join Trial
Venetoclax and Azacitidine Combined With Chidamide (VAC) for the Treatment of Newly Diagnosed Acute Monocytic Leukemia PHASE2 This study is to investigate the therapeutic efficacy and side effect of ve...
Show More Location
The First Affliated Hospital of Soochow University
Learn More & Join Trial
Study of Grifola Frondosa (Maitake), Azacitidine, and Lenalidomide PHASE1 The goal of this clinical research study is to find the highest tolerable d...
Show More Location
UT MD Anderson Cancer Center
Learn More & Join Trial
IDH Targeted/Non- Targeted vs Non-targeted/IDH-targeted Approaches in the Treatment of Newly Diagnosed IDH Mutated AML Patients Not Candidates for Intensive Induction Therapy (I- DATA Study) PHASE2 This phase II study compares the order of treatment with ivosidenib or enas...
Show More Location
University of Colorado
Learn More & Join Trial
Study of Vidaza (Azacitidine) Versus Support Treatment in Patients With Low Risk Myelodysplastic Syndrome (Low and Intermediate-1 IPSS) Without the 5q Deletion and Transfusion Dependent Anaemia PHASE2 Primary Outcome Measures:
• To evaluate the efficacy of treatment with Aza...
Show More Location
Hospital Reina Sofía, Servicio de Hematología
Learn More & Join Trial
Genotype-guided Treatment in DLBCL PHASE3 A multicenter, prospective, randomized, open-label, controlled trial to eva...
Show More Location
Ruijin Hospital, Shanghai Jiao Tong University School of Medicine
Learn More & Join Trial